One year after the launch of securPharm, several thousand false alarms still occur daily in Germany. What is the reason for this? The number of false alarms in Germany has already decreased significantly within one year. After the launch of securPharm, the false alarm rate was at 4.9 percent. In the meantime, it has dropped […]
Read More… from Why Are there Still so Many False Alarms in Germany?
Exactly one year ago to the day the anti-counterfeiting systems went live in Europe. We look back on the eventful and successful year 2019. Since February 2019, more than one billion drug packages have been given a unique digital identity – in Germany alone. More than six million scans are performed in pharmacies every day. […]
Read More… from One Year of Europe-wide Counterfeit Protection
Do you need a new and suitable and experienced pharma serialization provider? Changes in your serialization journey require a lot of time and a good action plan. Especially the beginning is often difficult in this process. Therefore, always remember to start planning early and go through our checklist “10 steps to start your serialization journey” […]
Read More… from 10 Steps to Start Your Serialization Journey
In the pharmaceutical industry, Digital Twins are being used to combat product counterfeiting. They not only offer added value for the industry but also ensure greater patient safety. In this white paper we answer the questions about how exactly Digital Twins are used in the pharmaceutical industry and what we have learned from the implementation […]
Read More… from Whitepaper: Digital Twins in the Pharmaceutical Industry
The pilot phase of HX Secur, our platform solution for delivering consolidated shipment data to hospitals, has now been completed. We can now present you our next generation of our hospital solution. We have… … further developed our solution… created simple interfaces for logistics experts… automated the connection for hospitals… partnered with hospital system providers. […]
The clock is ticking. Not only the end of the year is approaching, but also the deadline for all pharmaceutical manufacturers exporting to Russia. Therefore, we are even more pleased to have reached yet another milestone this year. After numerous tests between mytracekey PHARMA, the Russian importer and the Russian system MDLP, we have completed […]
Read More… from Russia Regulations Fulfilled: First Production Completed
Analyzing, automating, data integrity, patient centricity, data mining, process optimization – Pharma 4.0 is versatile. But what is meant by this and why does digitalization still have room for improvement in the pharmaceutical industry? Pharma 4.0 is part of the Internet of Things (IoT). The term describes the part of the IoT that affects the […]
Read More… from After Serialization: What Does Pharma 4.0 Mean?
Russia has been serializing since July 2020. The marking of Rx and OTC drugs with crypto codes is part of a large-scale track-and-trace project. It is intended to make an important contribution to greater patient and consumer safety in Russia. In addition to the safety aspect, however, economic interests are also in the foreground. Counterfeit […]
Read More… from Serialization in Russia: More than just a security measure
The Chemische Fabrik Kreussler & Co. GmbH with its pharmaceutical division became a tracekey customer almost one year ago. Both partners celebrated the successful completion of the implementation project for Kreussler’s business activities in the US with a customer visit. Together with tracekey, Kreussler implemented the DSCSA guideline and adapted its production to the US […]
Read More… from Successful implementation & customer visit at Kreussler Pharma
Pharmaceutical companies specializing in the production of over-the-counter drugs (OTC) have not been affected by pharmaceutical serialization so far. This is now changing for companies that are also active on the Russian market. The serialization requirements in Russia are much more complex than those of the EU-FMD. The so-called EU Counterfeiting Directive has been in […]